JOURNAL OF CHEMICAL RESEARCH 2010 469
MS: m/z = 269 (M-1, 25%), 76 (100%). Anal. Calcd for C16H18N2O2
(270.33): C, 71.09; H, 6.71; N, 10.36. Found: C, 71.00; H, 6.60; N,
10.30%.
2,2p-(Ethane-1,2-diylbis(azanediyl))bis(4,5-dioxo-4,5-dihydro-3H-
chromeno-[3,4-c]pyridine-1-carbonitrile) (14): A mixture of com-
pound (1b) (0.01 mol), 2-imino-chromene derivative (13) (0.02 mol)
and piperidine (0.01 mol) was refluxed in dioxane (30 mL) for 3 h.
The solid product which produced on heating was collected and
recrystallised from acetic acid as white yellow crystals; 62% yield as
brown crystals, m.p. 296–298 °C. IR (KBr): ν = 3312 (NH), 2196
(C≡N), and 1664 cm−1 (C=O). 1H NMR (DMSO-d6): δ = 4.00 (s, 4H,
2CH2), 6.56–8.22 (m, 8H, ArH), 8.83, 10.32 (2s, 4H, 4NH). MS:
m/z = 530 (M+-2, 7%), 497 (20%), 304 (18%), 218 (15%), 173 (75%),
89 (100%). Anal. Calcd for C28H16N6O6 (532.46): C, 63.16; H, 3.03;
N, 15.78. Found: C, 62.98; H, 2.82; N, 15.54%.
3,3p-(Ethane-1,2-diyl)bis(2-amino-5-imino-4-oxo-4,5-dihydro-3H-
chromeno-[3,4-c]pyridine-1-carbonitrile) (16): A mixture of com-
pound (12) (0.01 mol), malononitrile (0.02 mol) and piperidine
(0.01 mol) in dioxane (30 mL) was heated under reflux for 3h. The
solid product which produced on heating was collected by filtration
and recrystallised from acetic acid as brown crystals; 60% yield, m.p.
>300 °C. IR (KBr): ν = 3436, 3344, 3184 (NH and NH2), 2206 (C≡N),
and 1660 cm−1 (C=O). 1H NMR (DMSO-d6): δ = 4.01 (s, 4H, 2CH2),
6.57 (s, 4H, 2NH2; exchangeable with D2O), 7.11–7.63 (m, 8H, ArH),
9.21 (s, 2H, 2NH; exchangeable with D2O).Anal. Calcd for C28H18N8O4
(530.49): C, 63.39; H, 3.42; N, 21.12. Found: C, 63.30; H, 3.45; N,
21.16%.
N-Cyclohexyl-2-oxo-2H-chromene-3-carboxamide (4)
Method A: A mixture of cyanoacetamide derivative (1a) (0.01 mol),
salicyl-aldehyde (0.01 mol) and sodium acetate (0.01 mol) was
refluxed in acetic anhydride (30 mL) for 1hr. The solid product which
produced on heating was collected and recrystallised from dioxane as
white yellow crystals; 65% yield, m.p. 194–196 °C. IR (KBr):
ν = 3260 (NH), 3057 (CH-arom.), 2970, 2924 (stretching CH) and
1695, 1640 cm−1 (C=O). 1H NMR (DMSO-d6): δ = 1.21–1.39 (m, 6H,
cyclohexyl protons), 1.54–1.87 (m, 4H, cyclohexyl protons), 3.80–
3.82 (m, 1H, cyclohexyl proton), 7.41–8.00 (m, 4H, ArH), 8.84 (s, 1H,
chromene-H), 8.60 (d, 1H, NH; exchangeable with D2O). Anal. Calcd
for C16H17NO3 (271.31): C, 70.83; H, 6.32; N, 5.16. Found: C, 70.80;
H, 6.20; N, 5.10%.
Method B: A solution of the corresponding iminochromene deriva-
tives (3) (0.01 mol) in ethanol (30 mL), hydrochloric acid (5 mL) was
refluxed for 1h. The solid product which produced on heating was
collected and worked up as above.
2-Amino-3-cyclohexyl-5-imino-4-oxo-4,4a,5,10b-tetrahydro-3H-
chromeno[3,4-c]pyridine-1-carbonitrile (7): A mixture of compound
(4) (0.01 mol), malononitrile (0.01 mol) and piperidine (0.01 mol)
was refluxed in dioxane (30 mL) for 3h. The solid product which
produced on heating was collected and recrystallised from acetic acid
as white yellow crystals; 70% yield, m.p. 211–212 °C. IR (KBr):
ν = 3440, 3348, 3164 (NH&NH2), 2984 (stretching CH), 2208 (C≡N),
Received 9 May 2010; accepted 12 July 2010
Paper 1000112 doi: 10.3184/030823410X12812852410870
Published online: 30 August 2010
1
and 1650 cm−1 (C=O). H NMR (DMSO-d6): δ = 1.21–1.39 (m, 6H,
cyclohexyl protons), 1.56–1.87 (m, 4H, cyclohexyl protons), 3.68 (d,
1H, chromene H-3), 3.73 (hump, 1H, cyclohexyl proton), 4.67 (d, 1H,
chromene H-4), 6.95 (s, 2H, NH2; exchangeable with D2O), 7.08–8.50
(m, 4H, ArH), 10.80 (s, 1H, NH; exchangeable with D2O). MS:
m/z = 320 (M-NH2, 20%), 60 (100%). Anal. Calcd for C19H20N4O2
(336.39): C, 67.84; H, 5.99; N, 16.66. Found: C, 67.80; H, 5.85; N,
16.70%.
References
1
2
3
4
5
E. Budzisz, J.G. Wojciechowska, R. Zieba and B. Nawrot, New J. Chem.,
2002, 26, 1799.
K.C. Fylaktakidou, D.R. Gautam, D.J.H. Litina, C.A. Kontogiorgis, K.E.
Litinas and D.N. Nicolaides, J. Chem. Soc., Perkin Trans. 1, 2001, 3073.
K.J.M. Salazar, G.E.D. Paredes, L.R. Luncor, M.C. Max Young and M.J.
Kato, Phytochemistry, 2005, 66, 573.
M.H. Elnagdi, S.O. Abdallah, K.M. Ghoneim, E.M. Ebied and K.N.
Kassab, J. Chem. Res. (M), 1997, 375.
Z.M. Nofal, M.I. El-Zaharand and S.S. Abd El-Kariem, molcules, 2000, 5,
99.
2-Imimo-3-cyclohexyl-5-imino-4-oxo-4,5-dihydo-3H-chromeno
[3,4-c]pyridine-1-carbothioamide (11): A mixture of compound (4)
(0.01 mol), cyanothioacetamide (0.01 mol) and piperidine (0.01 mol)
was refluxed in dioxane (30 mL) for 3h. The solid product which
produced on heating was collected and recrystallised from acetic
acid as white yellow crystals; 70% yield, m.p. 246–247 °C. IR (KBr):
6
7
B.R. Martin and W.L. Dewey, J. Med. Chem., 1979, 22, 879.
W.A. Day and E.R. Lavagnino, US pat, May 1979, 4, 152, 450, 01; Chem.
Abstr., 1979, 91 56822r.
1
ν = 3432, 3360, 3170 (NH&NH2), and 1656 cm−1 (C=O). H NMR
(DMSO-d6): δ = 1.21–1.37 (m, 6H, cyclohexyl protons), 1.53–1.88
(m, 4H, cyclohexyl protons), 3.75 (hump, 1H, cyclohexyl proton),
6.85 (s, 2H, NH2), 7.11–8.70 (m, 6H, ArH + NH2), 10.77 (s, 1H, NH).
MS: m/z = 334 (M-H2S, 12%), 283 (68%), 266 (35%), 253 (40%), 227
(76%0, 190 (40%), 173 (75%), 146 (125%), 127(25%), 77 (58%), 63
(100%). Anal. Calcd for C19H20N4O2S (368.45): C, 61.94; H, 5.47; N,
15.21. Found: C, 61.90; H, 5.50; N, 15.10%.
N,Np-(Ethane-1,2-diyl)bis(2-imino-2H-chromene-3-carboxamide)
(12): A mixture of compound (1b) (0.01 mol), salicylaldehyde
(0.02 mol) and piperidine (0.01 mol) was refluxed in ethanol (30 mL)
for 3h. The solid product which produced on heating was collected
and recrystallised from dioxane as white yellow crystals; 61% yield,
m.p. 261–263 °C. IR (KBr): ν = 3319 (NH), 3058 (CH-arom.), and
1647 cm−1 (C=O). 1H NMR (DMSO-d6): δ = 4.21 (s, 4H, 2CH2),
6.24–8.42 (m, 10H, ArH + chromene H-4), 8.92, 10.44 (2s, 4H, 4NH;
exchangeable with D2O). 13C NMR (DMSO-d6): δ = 39.22, 114.77,
116.26, 118.41, 120.82, 127.91, 129, 84, 153.40, and 161.74. MS:
m/z = 402 (M+, 0.8%) 172 (100%). Anal. Calcd for C22H18N4O4
(402.40): C, 65.66; H, 4.51; N, 13.92. Found: C, 65.60; H, 4.40; N,
13.80%.
8
9
K. Mat, P. Stark and R.G. Meister, J. Med. Chem., 20, 17 (1977).
M.S.A. El-Gaby, M.M. Ghorab and S.M. Abdel-Gawad, Acta Pharm.,
1999, 49, 257.
10 M.S.A. El-Gaby, M.A. Zahran, M.M.F. Ismail and Y.A. Ammar, IL
Farmaco, 2000, 55, 227.
11 J. Guareschi, Chem. Ber., 1892, 326, 25.
12 H. Singh, L.D.S.Yadav and B.K. Bhattacharya, J. Indian Chem. Soc., 1979,
56, 1013.
13 N.C. Desai, Indian J. Chem. Sect. B, 1993, 32, 343.
14 X.M. Feng, R. Chen, X.C. Liu and Z.Y. Zhang, Chin. J. Appl. Chem., 1991,
8, 28.
15 P.S. Upadhyaz, R.N. Vansdadia and A.J. Baxi, Indian J. Chem. Sect. B,
1990, 29, 793.
16 Z.Y. Zhang, X. Chen, L.L. Wei and Z.L. Ma, Chem. Res. Chin. Univ., 1991,
7, 129.
17 C.N.O. Callaghan, (MRC Ireland, Dublin, Ire). Proc. Ir. Acad.; Sect. B,
1977, 77B, 533.
18 R. Cruickshank, J.P. Duguid, B.P. Marion and R.H.A. Swain, Medicinal
microbiology, 12th edn, vol. II, Churchill Livingstone, London, 1975,
p. 196.